Vaginal Cancer

​Vaginal cancer is not common. There are two main types of vaginal cancer: squamous cell carcinoma, and adenocarcinoma. Adenocarcinoma is more likely than squamous cell cancer to spread to the lungs and lymph nodes. A rare type of adenocarcinoma is linked to being exposed to diethylstilbestrol (DES) before birth. Adenocarcinomas not linked with being exposed to DES are most common in women after menopause.

Age and being exposed to the drug DES before birth affect a woman’s risk of vaginal cancer. Other risk factors for vaginal cancer are human papilloma virus (HPV) infection, a history of abnormal cells in the cervix or cervical cancer, a history of abnormal cells in the uterus or cancer of the uterus and having had a hysterectomy for health problems that affect the uterus.

It is estimated that in 2019 there will be more than 5,350 cases of vaginal cancer and about 1,430 deaths due to the disease in the United States, the National Cancer Institute reported.

Source: National Cancer Institute


The AACR - Impacting Cancer Research and Care

Communicating the Importance of HPV Vaccination

A recent study reports that how pediatricians talk to parents can affect whether or not they chose to have their child vaccinated against human papillomavirus (HPV).  Read More.

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300